1.Antineoplastic efficacy profiles of avapritinib and nintedanib in KIT D816V+ systemic mastocytosis: a preclinical study. Degenfeld-Schonburg, Gamperl, Stefanzl et al. Am J Cancer Res (2023) 13 (2), 355-378.
2.Aisen P (November 2004). Transferrin receptor 1. The International Journal of Biochemistry & Cell Biology. 36 (11): 2137–43. doi:10.1016/j.biocel.2004.02.007. PMID 15313461.
3.Moos T (November 2002). Brain iron homeostasis. Danish Medical Bulletin. 49 (4): 279–301. PMID 12553165.
4.Speeckaert MM, Speeckaert R, Delanghe JR (December 2010). Biological and clinical aspects of soluble transferrin receptor. Critical Reviews in Clinical Laboratory Sciences. 47 (5–6):213–28. doi:10.3109/10408363.2010.550461. PMID 21391831. S2CID 25425279.